Related Articles
Metabolic reprogramming and its clinical application in thyroid cancer (Review)
miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α Corrigendum in /10.3892/ijo.2022.5449
Tumor metabolic reprogramming in lung cancer progression (Review)
Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9
Potential roles of NEDD4 and NEDD4L and their utility as therapeutic targets in high‑incidence adult male cancers (Review)